Localization of NK1.1+ invariant Vα19 TCR+ cells in the liver with potential to promptly respond to TCR stimulation

Immunology Letters

Volumn 121, Issue 1, 2008, Pages 38-44

  Shimamura, Michio ^a   Huang, Yi Ying ^a   Migishima, Rika ^a   Yokoyama, Minesuke ^a   Saitoh, Takako ^a   Yamamura, Takashi ^b  

^a MITSUBISHI KAGAKU INSTITUTE OF LIFE SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Cytokine production; Development; Invariant TCR; NKT cell

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MATURATION; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; GENE OVEREXPRESSION; LIVER; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES; ANTIGENS, CD1; ANTIGENS, CD3; ANTIGENS, LY; CYTOKINES; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 54049132040     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.08.002     Document Type: Article

References (23)

1. Bendelac A., Rivera N.R., Park S.-H., and Roark J.H. Mouse CD1-specific NK1 T cells; development, specificity, and function. Annu. Rev. Immunol. 15 (1997) 535-562
2. Taniguchi M., Harada M., Kojo S., Nakayama T., and Wakao H. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21 (2003) 483-513
3. Bendelac A., Hunzike R.D., and Lantz O. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J. Exp. Med. 184 (1998) 1285-1293
4. - αβ T cells demonstrates preferential use of several Vβ genes and an invariant a chain. J Exp. Med. 178 (1993) 1-16
5. Tilloy F., Treiner E., Park S.-H., Garcia G., Lemonnier F., de la Salle H., et al. An invariant T cell receptor α chain define a novel TAP-independent major histocompatibility complex class Ib-restricted α/β T cell subpopulation in mammals. J. Exp. Med 189 (1999) 1907-1921
6. Shimamura M., and Huang Y.-Y. Presence of a novel subset of NKT cells bearing an invariant Vα19.1-Jα26 TCR α chain. FEBS Lett. 516 (2002) 97-100
7. Treiner E., Duban L., Bahram S., Radosavijevic M., Wanner V., Tilloy F., et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature (London) 422 (2003) 164-169
8. Kawachi I., Maldonado J., Strader C., and Gillfillan S. MR1-restricted Vα19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. J. Immunol. 176 (2006) 1618-1627
9. Hashimoto K., Hirai M., and Kurosawa Y. A gene outside the human MHC related to classical HLA class I genes. Science 269 (1995) 693-695
10. Smiley S.T., Kaplan M.N., and Grusby M.J. Immunoglobulin E production in the absence of interleukin 4-secreting CD1-dependent cells. Science 275 (2001) 977-979
11. Mombaerts P., Clarke A.R., Rudnicki M.A., Iacomini J., Itohara S., Lafáille J.J., et al. Mutations in T cell receptor genes α and β block thymocyte development at different stages. Nature (London) 360 (1992) 225-231
12. + T cells in vitro from fetal liver precursors. J. Immunol. 158 (1997) 3682-3689
13. Matsuda J.L., Naidenko O.V., Gapin L., Nakayama T., Taniguchi M., Wang C.-R., Koezuka Y., and Kronenberg M. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192 (2000) 741-7531627
14. Taniguchi M., Koseki H., Tokuhisa T., Masuda K., Sato H., Kondo E., et al. Essential requirement of an invariant Vα14 T cell antigen receptor expression in the development of natural killer T cells. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11025-11028
15. POS T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179 (1994) 1285-1295
16. Wilson M.T., Johansen C., Olivares-Villagomez D., Singh A.K., Stanic A.K., Wang C.-R., et al. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 10913-10918
17. Osman Y., Kawamura T., Naito T., Takeda K., Kaer L.V., Okumura K., et al. Activation of hepatic NKT cells and subsequent liver injury following administration of a-galactosylceramide. Eur. J. Immunol. 30 (2000) 1919-1928
18. Eberl G., Lees R., Smiley S.T., Taniguchi M., Grusby M.J., and MacDonald H.R. Tissue-specific segregation of CD1-dependent and CD1d-independent NK T cells. J. Immunol. 162 (1999) 6410-6419
19. Treiner E., and Lantz O. CD1d- and MR1-restricted invariant T cells: of mice and men. Curr. Opin. Immunol. 18 (2006) 519-526
20. Huaux F., Liu T., McGarry B., Ullenbruch M., and Phan S.H. Dual roles of IL-4 in lung injury and fibrosis. J. Immunol. 170 (2003) 2083-2092
21. Jakubzick C., Choi E.S., Joshi B.H., Keane M.P., Kunkel S.L., Puri R.K., and Hogaboam C.M. Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells. J. Immunol. 171 (2003) 2684-2693
22. Illés Z., Shimamura M., Newcombe J., Oku N., and Yamamura T. Accumulation of Vα7.2-Jα33 invariant T cells in human autoimmune inflammatory lesions. Int. Immunol. 16 (2004) 223-230
23. Croxford J.L., Miyake S., Huang Y.-Y., Shimamura M., and Yamamura T. Invariant Vα19i T cells regulate autoimmune inflammation. Nat. Immunol. 7 (2006) 987-994